The Jacks Lab
A Lustgarten Distinguished Lab at MIT
The Koch Institute for Integrative Cancer Research, a National Cancer Institute-designated Cancer Center, is a state-of-the-art cancer research facility as well as the hub of cancer research on the Massachusetts Institute of Technology (MIT) campus.
The Koch Institute brings together biologists and chemists along with biological, chemical, mechanical and materials science engineers, computer scientists, clinicians and others, to bring fresh perspectives and an interdisciplinary approach to advancing the fight against cancer. This multi-faceted group of investigators is at the core of the Koch Institute’s mission to develop new insights into cancer, as well as new tools and technologies to better treat, diagnose and prevent the disease.
NEW TECHNOLOGY IN PANCREATIC CANCER RESEARCH
Lab Leadership: Tyler Jacks, Ph.D.
Dr. Jacks is a Professor of Biology at MIT, a Howard Hughes Medical Institute investigator. Professor Jacks received his bachelor’s degree in biology from Harvard College, and his doctorate from the University of California, San Francisco, where he trained with Nobel Laureate Harold Varmus.
In recognition of his contributions to the study of cancer genetics, Dr. Jacks received the American Association for Cancer Research (AACR) Outstanding Achievement Award, the Amgen Award from the American Society of Biochemistry and Molecular Biology, the Paul Marks Prize for Cancer Research and the Sergio Lombroso Award in Cancer Research. In 2015, he was the recipient of the Killian Award, the highest honor the MIT faculty can bestow upon one of its members, and he served as co-chair of the Blue Ribbon Panel for Vice President Joe Biden’s Cancer Moonshot Initiative.